CLINICAL_TRIALS trial_result · 2011-07-25

Clinical Trial Update: Safety and Efficacy of Low Doses of V24343 in Obese Subjects [Phase 1]

Phase 1 study assessing safety and early efficacy of low doses of V24343 in adults with obesity; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Vernalis (R&D) Ltd | Conditions: Obesity | Phase 1 | Status: COMPLETED